73 results
8-K
EX-10.1
INM
InMed Pharmaceuticals Inc.
27 Jun 24
Entry into a Material Definitive Agreement
8:32pm
, telephone number, email address, photograph, social security number, bank information, or customer or account number; (ii) any information which would qualify
424B3
INM
InMed Pharmaceuticals Inc.
27 Jun 24
Prospectus supplement
6:27pm
CBDV synthesis to commercial quantities and initiated procurement of starting materials sufficient to meet expected customer demand in calendar 1Q2022 … the return to investors/shareholders;
Successfully developing CBDV to meet expected customer demand in early 2022;
Our ability to continue
8-K
EX-10.1
INM
InMed Pharmaceuticals Inc.
9 Feb 24
InMed Pharmaceuticals Strengthens Executive Leadership Team with Appointment of Ms. Netta Jagpal as Chief Financial Officer
12:34pm
information and strategies, customer lists, compilations, agreements and contractual records and correspondence; programs, devices, concepts, inventions … , customer, supplier, principal, shareholder, investor, collaborator, strategic partner, licensee, contact or prospect of the Company (or of its partners
8-K
EX-99.1
pa8trr ikh0v6cbqzwz
20 Jul 23
Regulation FD Disclosure
2:18pm
8-K
EX-10.2
i2qms742y9azp
13 Dec 22
InMed Announces Appointment of Interim Chief Financial Officer and Change of Auditor
3:47pm
8-K
EX-10.1
bgye8tc61m9bh
19 Jul 22
InMed Announces Appointment of Chief Operating Officer
7:43pm
424B3
66z7r579kvwqu4
6 Jul 22
Prospectus supplement
2:43pm
424B5
5hyqc3s14g4lgbapkaz9
3 Jun 22
Prospectus supplement for primary offering
9:45pm
424B3
wmk9igcygmxp
25 Apr 22
Prospectus supplement
5:02pm